JP2025517509A5 - - Google Patents

Info

Publication number
JP2025517509A5
JP2025517509A5 JP2024569498A JP2024569498A JP2025517509A5 JP 2025517509 A5 JP2025517509 A5 JP 2025517509A5 JP 2024569498 A JP2024569498 A JP 2024569498A JP 2024569498 A JP2024569498 A JP 2024569498A JP 2025517509 A5 JP2025517509 A5 JP 2025517509A5
Authority
JP
Japan
Prior art keywords
weeks
patient
administered
daily
hydrochloride monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024569498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517509A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/067326 external-priority patent/WO2023230451A2/en
Publication of JP2025517509A publication Critical patent/JP2025517509A/ja
Publication of JP2025517509A5 publication Critical patent/JP2025517509A5/ja
Pending legal-status Critical Current

Links

JP2024569498A 2022-05-23 2023-05-23 脊髄小脳失調症を治療する方法 Pending JP2025517509A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263344917P 2022-05-23 2022-05-23
US63/344,917 2022-05-23
PCT/US2023/067326 WO2023230451A2 (en) 2022-05-23 2023-05-23 Methods of treating spinocerebellar ataxias

Publications (2)

Publication Number Publication Date
JP2025517509A JP2025517509A (ja) 2025-06-05
JP2025517509A5 true JP2025517509A5 (cg-RX-API-DMAC7.html) 2026-04-03

Family

ID=88920175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024569498A Pending JP2025517509A (ja) 2022-05-23 2023-05-23 脊髄小脳失調症を治療する方法

Country Status (6)

Country Link
US (1) US20260124183A1 (cg-RX-API-DMAC7.html)
EP (1) EP4529485A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025517509A (cg-RX-API-DMAC7.html)
KR (1) KR20250020409A (cg-RX-API-DMAC7.html)
CN (1) CN120018855A (cg-RX-API-DMAC7.html)
WO (1) WO2023230451A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP2400349A1 (hu) * 2024-07-05 2026-01-28 Egis Gyógyszergyár Zrt. Troriluzole-hidroklorid-sók
WO2026062600A1 (en) * 2024-09-22 2026-03-26 Biohaven Therapeutics Ltd. Troriluzole for use in treating spinocerebellar ataxias

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154462A2 (en) * 2017-02-22 2018-08-30 Crispr Therapeutics Ag Materials and methods for treatment of spinocerebellar ataxia type 2 (sca2) and other spinocerebellar ataxia type 2 protein (atxn2) gene related conditions or disorders
PT3706739T (pt) * 2017-11-12 2024-12-04 Biohaven Therapeutics Ltd Utilização de profármacos de riluzol para tratar ataxias
US20210308111A1 (en) * 2018-07-27 2021-10-07 With Great Power, Llc Clinical Methods And Pharmaceutical Compositions Employing AMPA Receptor Antagonists To Treat Glioblastoma And Other Cancers
US20230067811A1 (en) * 2020-01-24 2023-03-02 University Of Virginia Patent Foundation Modulating lymphatic vessels in neurological disease

Similar Documents

Publication Publication Date Title
TW200916103A (en) Therapeutic compositions and methods
TW200412934A (en) Pharmaceutical formulations of modafinil
JP2022514089A5 (cg-RX-API-DMAC7.html)
JP2023535744A5 (cg-RX-API-DMAC7.html)
JP2010532372A5 (cg-RX-API-DMAC7.html)
JP2021502392A5 (cg-RX-API-DMAC7.html)
CL2024003601A1 (es) Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
KR20050085681A (ko) 프로테아제 억제제와 같은 사이토크롬 p450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(nnrti)를함유하는 배합물의 용도
CN101939001A (zh) 用于治疗卵巢癌的含有紫杉醇的组合
JP2001515041A5 (cg-RX-API-DMAC7.html)
CN1976723B (zh) 制备治疗或预防感染性疾病的药物的用途
JP2025511402A5 (cg-RX-API-DMAC7.html)
KR20050075012A (ko) 항암제에 의해 유발된 말초신경증의 예방 및/또는 치료를위한 아세틸-l-카르니틴
CN110755432A (zh) 烟酰胺在制备治疗手足皮肤反应制剂中的应用
JP2004091473A (ja) 色素沈着改善治療薬
AU2008257322B2 (en) Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to Parkinson's disease
US20110117070A1 (en) Compositions and methods for treating headache
CN115279344A (zh) 盐酸米托蒽醌脂质体的用途
JP2023516753A5 (cg-RX-API-DMAC7.html)
CN113557016A (zh) 衣壳组装调节剂固体配制品
TWI282735B (en) Combination and pharmaceutical formulation for the treatment of HBV infection
CN110891574B (zh) 用于预防和/或治疗肝细胞癌的美格列明
JP2023531919A5 (cg-RX-API-DMAC7.html)
JP2024518426A5 (cg-RX-API-DMAC7.html)
JP2023518430A (ja) 感染症の治療におけるブシラミンの使用